Evidence map›Paper›PMID 39698462›Full record

ArticleNanoscale advances2025

Toward nanofabrication of SERS substrates with two-photon polymerization.

Tatevik Chalyan, Mehdi Feizpour, Qing Liu, Koen Vanmol, Núria Solerdelcoll, Gen Takebe, Hugo Thienpont, Heidi Ottevaere

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanoscale advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tatevik ChalyanBrussels Photonics (B-PHOT), Department of Applied Physics and Photonics, Vrije Universiteit Brussel and Flanders Make Pleinlaan 2 B-1050 Brussels Belgium tatevik.chalyan@vub.be.ORCID https://orcid.org/0000-0002-1179-2969
Mehdi FeizpourBrussels Photonics (B-PHOT), Department of Applied Physics and Photonics, Vrije Universiteit Brussel and Flanders Make Pleinlaan 2 B-1050 Brussels Belgium tatevik.chalyan@vub.be.ORCID https://orcid.org/0000-0003-0543-6455
Qing LiuBrussels Photonics (B-PHOT), Department of Applied Physics and Photonics, Vrije Universiteit Brussel and Flanders Make Pleinlaan 2 B-1050 Brussels Belgium tatevik.chalyan@vub.be.
Koen VanmolBrussels Photonics (B-PHOT), Department of Applied Physics and Photonics, Vrije Universiteit Brussel and Flanders Make Pleinlaan 2 B-1050 Brussels Belgium tatevik.chalyan@vub.be.
Núria SolerdelcollBrussels Photonics (B-PHOT), Department of Applied Physics and Photonics, Vrije Universiteit Brussel and Flanders Make Pleinlaan 2 B-1050 Brussels Belgium tatevik.chalyan@vub.be.
Gen TakebeBrussels Photonics (B-PHOT), Department of Applied Physics and Photonics, Vrije Universiteit Brussel and Flanders Make Pleinlaan 2 B-1050 Brussels Belgium tatevik.chalyan@vub.be.
Hugo ThienpontBrussels Photonics (B-PHOT), Department of Applied Physics and Photonics, Vrije Universiteit Brussel and Flanders Make Pleinlaan 2 B-1050 Brussels Belgium tatevik.chalyan@vub.be.
Heidi OttevaereBrussels Photonics (B-PHOT), Department of Applied Physics and Photonics, Vrije Universiteit Brussel and Flanders Make Pleinlaan 2 B-1050 Brussels Belgium tatevik.chalyan@vub.be.ORCID https://orcid.org/0000-0001-7327-1205

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surface-enhanced Raman spectroscopy (SERS) has shown its ability to characterize biological substances down to a single-molecule level without a specific biorecognition mechanism. Various nanofabrication technologies enable SERS substrate prototyping and mass manufacturing. This study reports a complete cycle of design, fabrication, prototyping, and metrology of SERS substrates based on two-photon polymerization (2PP). Highly controllable direct laser writing allows the fabrication of individual nanopillars with up to an aspect ratio of 4. The developed SERS substrates show up to 10

Identifiers

PMID39698462
PMCPMC11651303

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.